

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.37366020 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.37366020 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.32421142 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.26169031 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.26169031 |
| 6 | glyoxylate metabolic process (GO:0046487) | 4.04590313 |
| 7 | positive regulation of actin filament depolymerization (GO:0030836) | 3.96208932 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 3.94198815 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 3.93619737 |
| 10 | lysine metabolic process (GO:0006553) | 3.86107085 |
| 11 | lysine catabolic process (GO:0006554) | 3.86107085 |
| 12 | glutamate metabolic process (GO:0006536) | 3.84007539 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 3.83887257 |
| 14 | cysteine metabolic process (GO:0006534) | 3.79950740 |
| 15 | serine family amino acid catabolic process (GO:0009071) | 3.70742722 |
| 16 | tryptophan catabolic process (GO:0006569) | 3.64254636 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.64254636 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.64254636 |
| 19 | cellular modified amino acid catabolic process (GO:0042219) | 3.63109879 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.60890069 |
| 21 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60839782 |
| 22 | fibroblast migration (GO:0010761) | 3.55517547 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 3.47351411 |
| 24 | homocysteine metabolic process (GO:0050667) | 3.46468861 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.46080132 |
| 26 | vocalization behavior (GO:0071625) | 3.43808247 |
| 27 | kynurenine metabolic process (GO:0070189) | 3.43677532 |
| 28 | negative regulation of protein localization to cell surface (GO:2000009) | 3.41520100 |
| 29 | vascular smooth muscle contraction (GO:0014829) | 3.41333068 |
| 30 | actin filament depolymerization (GO:0030042) | 3.39137021 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.37888217 |
| 32 | tryptophan metabolic process (GO:0006568) | 3.32752378 |
| 33 | bile acid biosynthetic process (GO:0006699) | 3.31196682 |
| 34 | nucleobase catabolic process (GO:0046113) | 3.29138918 |
| 35 | serine family amino acid biosynthetic process (GO:0009070) | 3.29051120 |
| 36 | ketone body metabolic process (GO:1902224) | 3.28020787 |
| 37 | * alpha-amino acid catabolic process (GO:1901606) | 3.20990333 |
| 38 | presynaptic membrane assembly (GO:0097105) | 3.12969367 |
| 39 | reverse cholesterol transport (GO:0043691) | 3.12824860 |
| 40 | * cellular amino acid catabolic process (GO:0009063) | 3.12179681 |
| 41 | membrane assembly (GO:0071709) | 3.11846348 |
| 42 | aspartate family amino acid catabolic process (GO:0009068) | 3.10973920 |
| 43 | glutamate secretion (GO:0014047) | 3.10803417 |
| 44 | dicarboxylic acid catabolic process (GO:0043649) | 3.10433475 |
| 45 | positive regulation of protein autophosphorylation (GO:0031954) | 3.09288317 |
| 46 | drug catabolic process (GO:0042737) | 3.09212861 |
| 47 | chondrocyte proliferation (GO:0035988) | 3.06556661 |
| 48 | negative regulation of sodium ion transport (GO:0010766) | 3.06098584 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 3.04567748 |
| 50 | alanine transport (GO:0032328) | 3.04505913 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.02999094 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.02265969 |
| 53 | cellular glucuronidation (GO:0052695) | 3.01941531 |
| 54 | L-serine metabolic process (GO:0006563) | 3.01277713 |
| 55 | urate metabolic process (GO:0046415) | 3.00943058 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 2.98956977 |
| 57 | muscle cell cellular homeostasis (GO:0046716) | 2.98688770 |
| 58 | negative regulation of axon guidance (GO:1902668) | 2.98346447 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 2.98321525 |
| 60 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.96711210 |
| 61 | coenzyme catabolic process (GO:0009109) | 2.95972385 |
| 62 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.95645847 |
| 63 | aromatic amino acid family metabolic process (GO:0009072) | 2.94148987 |
| 64 | low-density lipoprotein particle remodeling (GO:0034374) | 2.91322954 |
| 65 | fructose metabolic process (GO:0006000) | 2.90948392 |
| 66 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.90592319 |
| 67 | urea metabolic process (GO:0019627) | 2.89464057 |
| 68 | urea cycle (GO:0000050) | 2.89464057 |
| 69 | exogenous drug catabolic process (GO:0042738) | 2.86634998 |
| 70 | ovulation cycle (GO:0042698) | 2.81732316 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 2.81299632 |
| 72 | postsynaptic membrane organization (GO:0001941) | 2.79702503 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.76097261 |
| 74 | C4-dicarboxylate transport (GO:0015740) | 2.75939218 |
| 75 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.75703864 |
| 76 | regulation of plasminogen activation (GO:0010755) | 2.75571130 |
| 77 | glucuronate metabolic process (GO:0019585) | 2.74472111 |
| 78 | uronic acid metabolic process (GO:0006063) | 2.74472111 |
| 79 | response to gravity (GO:0009629) | 2.73511250 |
| 80 | * glutamine family amino acid catabolic process (GO:0009065) | 2.73449166 |
| 81 | bile acid metabolic process (GO:0008206) | 2.72647949 |
| 82 | tyrosine metabolic process (GO:0006570) | 2.72554847 |
| 83 | synaptic vesicle exocytosis (GO:0016079) | 2.71312396 |
| 84 | plasma lipoprotein particle remodeling (GO:0034369) | 2.71240128 |
| 85 | protein-lipid complex remodeling (GO:0034368) | 2.71240128 |
| 86 | macromolecular complex remodeling (GO:0034367) | 2.71240128 |
| 87 | short-chain fatty acid metabolic process (GO:0046459) | 2.70998998 |
| 88 | synaptic vesicle maturation (GO:0016188) | 2.68395062 |
| 89 | neurotransmitter secretion (GO:0007269) | 2.67944990 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.66914417 |
| 91 | protein carboxylation (GO:0018214) | 2.66914417 |
| 92 | regulation of bile acid biosynthetic process (GO:0070857) | 2.66793856 |
| 93 | collagen fibril organization (GO:0030199) | 2.66487298 |
| 94 | positive regulation of muscle hypertrophy (GO:0014742) | 2.66476665 |
| 95 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.66476665 |
| 96 | presynaptic membrane organization (GO:0097090) | 2.65762648 |
| 97 | epoxygenase P450 pathway (GO:0019373) | 2.64257231 |
| 98 | layer formation in cerebral cortex (GO:0021819) | 2.63471619 |
| 99 | nitrogen cycle metabolic process (GO:0071941) | 2.60684834 |
| 100 | protein heterotetramerization (GO:0051290) | 2.60467110 |
| 101 | drug transmembrane transport (GO:0006855) | 2.57882475 |
| 102 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.57880379 |
| 103 | regulation of dendritic spine development (GO:0060998) | 2.57726371 |
| 104 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.56790844 |
| 105 | negative regulation of sterol transport (GO:0032372) | 2.56168599 |
| 106 | negative regulation of cholesterol transport (GO:0032375) | 2.56168599 |
| 107 | neuron cell-cell adhesion (GO:0007158) | 2.56122612 |
| 108 | locomotory exploration behavior (GO:0035641) | 2.55799370 |
| 109 | regulation of Rac protein signal transduction (GO:0035020) | 2.55720608 |
| 110 | phosphate ion transport (GO:0006817) | 2.54421419 |
| 111 | dermatan sulfate biosynthetic process (GO:0030208) | 2.54036433 |
| 112 | glycine metabolic process (GO:0006544) | 2.53682678 |
| 113 | generation of neurons (GO:0048699) | 2.53372950 |
| 114 | indolalkylamine metabolic process (GO:0006586) | 2.53068088 |
| 115 | peptidyl-cysteine modification (GO:0018198) | 2.53007164 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 2.52750921 |
| 117 | regulation of protein activation cascade (GO:2000257) | 2.51270994 |
| 118 | 2-oxoglutarate metabolic process (GO:0006103) | 2.51239298 |
| 119 | amine catabolic process (GO:0009310) | 2.51077124 |
| 120 | cellular biogenic amine catabolic process (GO:0042402) | 2.51077124 |
| 121 | * organic acid catabolic process (GO:0016054) | 2.51063583 |
| 122 | * carboxylic acid catabolic process (GO:0046395) | 2.51063583 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 2.49352245 |
| 124 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.47434211 |
| 125 | cell communication by electrical coupling (GO:0010644) | 2.47033529 |
| 126 | cullin deneddylation (GO:0010388) | 2.45705848 |
| 127 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.45576690 |
| 128 | phosphate ion transmembrane transport (GO:0035435) | 2.45350687 |
| 129 | proline transport (GO:0015824) | 2.43968643 |
| 130 | succinate metabolic process (GO:0006105) | 2.43832383 |
| 131 | artery development (GO:0060840) | 2.43516083 |
| 132 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.42513497 |
| 133 | regulation of axon guidance (GO:1902667) | 2.41916552 |
| 134 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.41009382 |
| 135 | cell adhesion mediated by integrin (GO:0033627) | 2.36683030 |
| 136 | lymphangiogenesis (GO:0001946) | 2.36650325 |
| 137 | limb bud formation (GO:0060174) | 2.36090925 |
| 138 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.35510348 |
| 139 | lipid particle organization (GO:0034389) | 2.33834669 |
| 140 | regulation of synapse assembly (GO:0051963) | 2.33782690 |
| 141 | axonal fasciculation (GO:0007413) | 2.33594829 |
| 142 | regulation of protein localization to cell surface (GO:2000008) | 2.31628510 |
| 143 | intraciliary transport (GO:0042073) | 2.30444749 |
| 144 | positive regulation of fibroblast migration (GO:0010763) | 2.29890200 |
| 145 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.29740090 |
| 146 | ventricular cardiac muscle cell development (GO:0055015) | 2.27957146 |
| 147 | cellular response to interferon-alpha (GO:0035457) | 2.26773811 |
| 148 | axon extension (GO:0048675) | 2.26469889 |
| 149 | neuron recognition (GO:0008038) | 2.23584343 |
| 150 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.22931504 |
| 151 | positive regulation of protein depolymerization (GO:1901881) | 2.21154023 |
| 152 | response to pheromone (GO:0019236) | 2.19951257 |
| 153 | protein deneddylation (GO:0000338) | 2.19072694 |
| 154 | female gonad development (GO:0008585) | 2.17772783 |
| 155 | positive regulation of vesicle fusion (GO:0031340) | 2.17201971 |
| 156 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.17116236 |
| 157 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.16847813 |
| 158 | regulation of cell communication by electrical coupling (GO:0010649) | 2.13678610 |
| 159 | startle response (GO:0001964) | 2.12872056 |
| 160 | positive regulation of synapse assembly (GO:0051965) | 2.11859752 |
| 161 | branched-chain amino acid catabolic process (GO:0009083) | 2.10932315 |
| 162 | regulation of keratinocyte proliferation (GO:0010837) | 2.10506554 |
| 163 | neuron projection extension (GO:1990138) | 2.09051240 |
| 164 | protein localization to cell surface (GO:0034394) | 2.08688972 |
| 165 | cholesterol biosynthetic process (GO:0006695) | 2.08281425 |
| 166 | glycosphingolipid biosynthetic process (GO:0006688) | 2.06552816 |
| 167 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.05376803 |
| 168 | axon extension involved in axon guidance (GO:0048846) | 2.05376803 |
| 169 | regulation of neurotransmitter uptake (GO:0051580) | 2.03870890 |
| 170 | neuronal action potential propagation (GO:0019227) | 2.02367843 |
| 171 | type B pancreatic cell proliferation (GO:0044342) | 2.02070532 |
| 172 | regulation of sarcomere organization (GO:0060297) | 2.01822224 |
| 173 | cilium morphogenesis (GO:0060271) | 1.99800508 |
| 174 | sterol biosynthetic process (GO:0016126) | 1.99606622 |
| 175 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 1.98921092 |
| 176 | outer ear morphogenesis (GO:0042473) | 1.98584224 |
| 177 | oligodendrocyte differentiation (GO:0048709) | 1.98521951 |
| 178 | metanephric mesenchyme development (GO:0072075) | 1.97994517 |
| 179 | heart contraction (GO:0060047) | 1.97596938 |
| 180 | heart process (GO:0003015) | 1.97596938 |
| 181 | protein prenylation (GO:0018342) | 1.97032285 |
| 182 | prenylation (GO:0097354) | 1.97032285 |
| 183 | hippo signaling (GO:0035329) | 1.96237139 |
| 184 | negative regulation of keratinocyte proliferation (GO:0010839) | 1.96096324 |
| 185 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 1.95377469 |
| 186 | vagina development (GO:0060068) | 1.94667847 |
| 187 | kidney mesenchyme development (GO:0072074) | 1.94111034 |
| 188 | negative chemotaxis (GO:0050919) | 1.93471074 |
| 189 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 1.93395095 |
| 190 | tonic smooth muscle contraction (GO:0014820) | 1.93232675 |
| 191 | vasoconstriction (GO:0042310) | 1.92458904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.56005403 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.26766228 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.13477746 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.06165109 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.04333296 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.96035660 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.71675706 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40927983 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40780282 |
| 10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37737479 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32429655 |
| 12 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24196601 |
| 13 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.22782784 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.15933612 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15326503 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12868858 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.07239740 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.03225982 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.01997495 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00200984 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00200984 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.99770029 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98775785 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96383178 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.95623539 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92018151 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.91225765 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90491143 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90250182 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.89665454 |
| 31 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.83721670 |
| 32 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82606012 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82376380 |
| 34 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80403903 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73154665 |
| 36 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72771686 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.71584461 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69645182 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69551184 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69190878 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.62030108 |
| 42 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.61512646 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56984090 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54417199 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.51153355 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48114845 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47772455 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47766713 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45392602 |
| 50 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.43061307 |
| 51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.42270894 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42015468 |
| 53 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41089119 |
| 54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40712176 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37474704 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37276545 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36215855 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36036401 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35562162 |
| 60 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34244214 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.33809491 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33700749 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32696839 |
| 64 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.30404914 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29931632 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29656349 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28659608 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26576832 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23940100 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21316982 |
| 71 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21235518 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20887292 |
| 73 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20811463 |
| 74 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20691112 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19543246 |
| 76 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19386105 |
| 77 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18323046 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16886569 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16676467 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16542335 |
| 81 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.16400454 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15534485 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15360952 |
| 84 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15262317 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15018845 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15018845 |
| 87 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14927157 |
| 88 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14759416 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14750579 |
| 90 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13917471 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13435239 |
| 92 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.13135125 |
| 93 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13041748 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10474657 |
| 95 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10464015 |
| 96 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10307258 |
| 97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09504589 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09504589 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09417187 |
| 100 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09267074 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08943101 |
| 102 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.08409620 |
| 103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08254027 |
| 104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08249057 |
| 105 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08186792 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07732873 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07208705 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07188034 |
| 109 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07100803 |
| 110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06621260 |
| 111 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05409101 |
| 112 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.05215368 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05193861 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05019572 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03931299 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03540289 |
| 117 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03353375 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02820089 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02696060 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01799241 |
| 121 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01075409 |
| 122 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01006174 |
| 123 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00664887 |
| 124 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00441454 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00213278 |
| 126 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98135916 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96814627 |
| 128 | JUN_21703547_ChIP-Seq_K562_Human | 0.96553968 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.96372050 |
| 130 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96240590 |
| 131 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95647129 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95600957 |
| 133 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95551171 |
| 134 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94289362 |
| 135 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94145543 |
| 136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92773911 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91521720 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90171054 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89448594 |
| 140 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89228713 |
| 141 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88210083 |
| 142 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88004973 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85290850 |
| 144 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83386841 |
| 145 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82257293 |
| 146 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81961830 |
| 147 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81720686 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81476445 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81060180 |
| 150 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80562715 |
| 151 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80510485 |
| 152 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78422735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.14847863 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.98692179 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.24891972 |
| 4 | MP0005365_abnormal_bile_salt | 3.07357503 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.99171625 |
| 6 | MP0005623_abnormal_meninges_morphology | 2.89221921 |
| 7 | MP0006054_spinal_hemorrhage | 2.70065397 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.69512126 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.54375766 |
| 10 | * MP0005332_abnormal_amino_acid | 2.46056524 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.32900944 |
| 12 | MP0004858_abnormal_nervous_system | 2.31191395 |
| 13 | MP0003252_abnormal_bile_duct | 2.13316119 |
| 14 | MP0003329_amyloid_beta_deposits | 2.08318008 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.06636033 |
| 16 | MP0001299_abnormal_eye_distance/ | 1.83712581 |
| 17 | MP0003195_calcinosis | 1.80769355 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 1.78943577 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 1.78419338 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.78112259 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.75368138 |
| 22 | MP0000749_muscle_degeneration | 1.68698952 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.66723678 |
| 24 | MP0001958_emphysema | 1.65020338 |
| 25 | MP0002063_abnormal_learning/memory/cond | 1.63946026 |
| 26 | MP0005171_absent_coat_pigmentation | 1.60475968 |
| 27 | MP0005503_abnormal_tendon_morphology | 1.58795237 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.47762652 |
| 29 | MP0009745_abnormal_behavioral_response | 1.47039574 |
| 30 | MP0002064_seizures | 1.46773363 |
| 31 | MP0009046_muscle_twitch | 1.44626592 |
| 32 | MP0003941_abnormal_skin_development | 1.42152573 |
| 33 | MP0003755_abnormal_palate_morphology | 1.41206490 |
| 34 | MP0000778_abnormal_nervous_system | 1.40735463 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.38981906 |
| 36 | MP0003279_aneurysm | 1.38302775 |
| 37 | MP0001984_abnormal_olfaction | 1.36688111 |
| 38 | MP0004270_analgesia | 1.34759878 |
| 39 | MP0002736_abnormal_nociception_after | 1.33483679 |
| 40 | MP0000516_abnormal_urinary_system | 1.33371753 |
| 41 | MP0005367_renal/urinary_system_phenotyp | 1.33371753 |
| 42 | MP0002822_catalepsy | 1.32935838 |
| 43 | MP0002751_abnormal_autonomic_nervous | 1.31984098 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.31155442 |
| 45 | MP0005187_abnormal_penis_morphology | 1.31113440 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.30892678 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.30465621 |
| 48 | MP0002938_white_spotting | 1.28934582 |
| 49 | MP0002102_abnormal_ear_morphology | 1.24721649 |
| 50 | MP0001529_abnormal_vocalization | 1.23689727 |
| 51 | MP0009840_abnormal_foam_cell | 1.22282541 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.21642179 |
| 53 | MP0002168_other_aberrant_phenotype | 1.20649052 |
| 54 | MP0001486_abnormal_startle_reflex | 1.19950098 |
| 55 | MP0001177_atelectasis | 1.19747022 |
| 56 | MP0009697_abnormal_copulation | 1.19452111 |
| 57 | MP0003385_abnormal_body_wall | 1.18535973 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.16320822 |
| 59 | MP0003937_abnormal_limbs/digits/tail_de | 1.14956427 |
| 60 | MP0004885_abnormal_endolymph | 1.14551476 |
| 61 | MP0003283_abnormal_digestive_organ | 1.14102808 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.13161375 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.12400680 |
| 64 | MP0005248_abnormal_Harderian_gland | 1.11863059 |
| 65 | MP0000604_amyloidosis | 1.11160332 |
| 66 | MP0002233_abnormal_nose_morphology | 1.10569067 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.07333176 |
| 68 | MP0003011_delayed_dark_adaptation | 1.06185848 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.05757569 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.05411334 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.02794234 |
| 72 | MP0001440_abnormal_grooming_behavior | 1.02640995 |
| 73 | MP0003122_maternal_imprinting | 1.00887678 |
| 74 | MP0010368_abnormal_lymphatic_system | 1.00675865 |
| 75 | MP0005275_abnormal_skin_tensile | 1.00480035 |
| 76 | MP0003942_abnormal_urinary_system | 1.00452034 |
| 77 | MP0004272_abnormal_basement_membrane | 1.00207159 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99854746 |
| 79 | MP0000762_abnormal_tongue_morphology | 0.99484105 |
| 80 | MP0002733_abnormal_thermal_nociception | 0.99385221 |
| 81 | MP0002090_abnormal_vision | 0.99075484 |
| 82 | MP0009053_abnormal_anal_canal | 0.98882422 |
| 83 | MP0002067_abnormal_sensory_capabilities | 0.98523334 |
| 84 | * MP0005595_abnormal_vascular_smooth | 0.96753491 |
| 85 | MP0003868_abnormal_feces_composition | 0.96402513 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.96362497 |
| 87 | MP0003880_abnormal_central_pattern | 0.94913222 |
| 88 | MP0001542_abnormal_bone_strength | 0.94721688 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.94328102 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.94193328 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.93376599 |
| 92 | MP0004133_heterotaxia | 0.93279966 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.92250989 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 0.91665090 |
| 95 | MP0002928_abnormal_bile_duct | 0.90725417 |
| 96 | MP0002557_abnormal_social/conspecific_i | 0.90565181 |
| 97 | MP0000613_abnormal_salivary_gland | 0.90024360 |
| 98 | MP0001293_anophthalmia | 0.89793716 |
| 99 | MP0003690_abnormal_glial_cell | 0.87882545 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.87293192 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.87022697 |
| 102 | MP0003115_abnormal_respiratory_system | 0.86393498 |
| 103 | MP0005395_other_phenotype | 0.85613923 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.85612430 |
| 105 | MP0002108_abnormal_muscle_morphology | 0.85399514 |
| 106 | MP0004043_abnormal_pH_regulation | 0.85193751 |
| 107 | MP0002896_abnormal_bone_mineralization | 0.84524151 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.84039129 |
| 109 | MP0002184_abnormal_innervation | 0.81279004 |
| 110 | MP0010030_abnormal_orbit_morphology | 0.80621594 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.80456807 |
| 112 | MP0001756_abnormal_urination | 0.80397729 |
| 113 | MP0000427_abnormal_hair_cycle | 0.80209350 |
| 114 | MP0001286_abnormal_eye_development | 0.80204877 |
| 115 | MP0003935_abnormal_craniofacial_develop | 0.80124815 |
| 116 | MP0003634_abnormal_glial_cell | 0.79368707 |
| 117 | MP0000026_abnormal_inner_ear | 0.79336663 |
| 118 | MP0004233_abnormal_muscle_weight | 0.78832147 |
| 119 | MP0005508_abnormal_skeleton_morphology | 0.78815290 |
| 120 | MP0002653_abnormal_ependyma_morphology | 0.78137494 |
| 121 | MP0004883_abnormal_blood_vessel | 0.77788181 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 0.77570466 |
| 123 | MP0002163_abnormal_gland_morphology | 0.77563668 |
| 124 | MP0002735_abnormal_chemical_nociception | 0.77505606 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.76795929 |
| 126 | MP0005253_abnormal_eye_physiology | 0.76220004 |
| 127 | MP0001502_abnormal_circadian_rhythm | 0.75694311 |
| 128 | MP0003186_abnormal_redox_activity | 0.75391286 |
| 129 | MP0001666_abnormal_nutrient_absorption | 0.74974461 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.74930981 |
| 131 | MP0009250_abnormal_appendicular_skeleto | 0.74775527 |
| 132 | MP0003632_abnormal_nervous_system | 0.73994607 |
| 133 | MP0005083_abnormal_biliary_tract | 0.73962968 |
| 134 | MP0004142_abnormal_muscle_tone | 0.73746830 |
| 135 | MP0002272_abnormal_nervous_system | 0.72747202 |
| 136 | MP0000955_abnormal_spinal_cord | 0.72570378 |
| 137 | MP0004811_abnormal_neuron_physiology | 0.72554592 |
| 138 | MP0005423_abnormal_somatic_nervous | 0.72232098 |
| 139 | MP0002066_abnormal_motor_capabilities/c | 0.71610512 |
| 140 | MP0005386_behavior/neurological_phenoty | 0.71606603 |
| 141 | MP0004924_abnormal_behavior | 0.71606603 |
| 142 | MP0001970_abnormal_pain_threshold | 0.69183697 |
| 143 | MP0002152_abnormal_brain_morphology | 0.68518246 |
| 144 | MP0002069_abnormal_eating/drinking_beha | 0.68276794 |
| 145 | MP0002882_abnormal_neuron_morphology | 0.67029115 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.65881109 |
| 147 | MP0002282_abnormal_trachea_morphology | 0.64860506 |
| 148 | MP0003631_nervous_system_phenotype | 0.64042712 |
| 149 | MP0002089_abnormal_postnatal_growth/wei | 0.63847802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.08928866 |
| 2 | Xanthomatosis (HP:0000991) | 3.89615364 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78435578 |
| 4 | Hyperglycinemia (HP:0002154) | 3.67963574 |
| 5 | Arterial tortuosity (HP:0005116) | 3.66802757 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.64129195 |
| 7 | Aortic dissection (HP:0002647) | 3.60168221 |
| 8 | Hyperglycinuria (HP:0003108) | 3.50461844 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 3.49194167 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.49194167 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.48139647 |
| 12 | Delayed gross motor development (HP:0002194) | 3.45890191 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.30744459 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.27511190 |
| 15 | Hyperventilation (HP:0002883) | 3.19352276 |
| 16 | Hyperammonemia (HP:0001987) | 3.16833037 |
| 17 | Gout (HP:0001997) | 3.14085128 |
| 18 | Popliteal pterygium (HP:0009756) | 3.03185469 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.01353633 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 2.88938706 |
| 21 | Hypolipoproteinemia (HP:0010981) | 2.87949153 |
| 22 | Megalencephaly (HP:0001355) | 2.86036958 |
| 23 | Ketosis (HP:0001946) | 2.83088103 |
| 24 | Delayed CNS myelination (HP:0002188) | 2.79052174 |
| 25 | Myokymia (HP:0002411) | 2.73659308 |
| 26 | Polyphagia (HP:0002591) | 2.73569259 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.69269923 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 2.65291466 |
| 29 | Pheochromocytoma (HP:0002666) | 2.57515406 |
| 30 | Hydroxyprolinuria (HP:0003080) | 2.54515200 |
| 31 | Abnormality of proline metabolism (HP:0010907) | 2.54515200 |
| 32 | Back pain (HP:0003418) | 2.54420862 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.53702084 |
| 34 | Atonic seizures (HP:0010819) | 2.51191178 |
| 35 | Ketoacidosis (HP:0001993) | 2.50105134 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.49986178 |
| 37 | Aplasia involving bones of the extremities (HP:0009825) | 2.47178301 |
| 38 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.47178301 |
| 39 | Aplasia of the phalanges of the hand (HP:0009802) | 2.47178301 |
| 40 | Soft skin (HP:0000977) | 2.35498533 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.33061311 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.32810228 |
| 43 | Abnormality of the ischium (HP:0003174) | 2.32760014 |
| 44 | Status epilepticus (HP:0002133) | 2.29662363 |
| 45 | Hemiparesis (HP:0001269) | 2.29040259 |
| 46 | Mitral stenosis (HP:0001718) | 2.28734698 |
| 47 | Microglossia (HP:0000171) | 2.27849546 |
| 48 | Hepatoblastoma (HP:0002884) | 2.27473045 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26760371 |
| 50 | True hermaphroditism (HP:0010459) | 2.25273947 |
| 51 | Sensorimotor neuropathy (HP:0007141) | 2.24016099 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.23871584 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.23871584 |
| 54 | Amyotrophic lateral sclerosis (HP:0007354) | 2.22355278 |
| 55 | Nemaline bodies (HP:0003798) | 2.22201818 |
| 56 | Epileptic encephalopathy (HP:0200134) | 2.18697833 |
| 57 | Progressive cerebellar ataxia (HP:0002073) | 2.18641239 |
| 58 | Hypoplastic ischia (HP:0003175) | 2.18300564 |
| 59 | Epidermoid cyst (HP:0200040) | 2.16080783 |
| 60 | Abnormality of the anterior horn cell (HP:0006802) | 2.15941119 |
| 61 | Degeneration of anterior horn cells (HP:0002398) | 2.15941119 |
| 62 | Neuroendocrine neoplasm (HP:0100634) | 2.15641532 |
| 63 | Abnormal gallbladder physiology (HP:0012438) | 2.15167582 |
| 64 | Cholecystitis (HP:0001082) | 2.15167582 |
| 65 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.11861911 |
| 66 | Abnormality of dentin (HP:0010299) | 2.10986975 |
| 67 | Focal motor seizures (HP:0011153) | 2.07436205 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.07343117 |
| 69 | Focal seizures (HP:0007359) | 2.07264293 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.05918738 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.04671180 |
| 72 | Astrocytoma (HP:0009592) | 2.04633280 |
| 73 | Abnormality of the astrocytes (HP:0100707) | 2.04633280 |
| 74 | Pterygium (HP:0001059) | 2.03420227 |
| 75 | Lethargy (HP:0001254) | 2.02508250 |
| 76 | Proximal tubulopathy (HP:0000114) | 2.01401092 |
| 77 | Premature rupture of membranes (HP:0001788) | 2.00397991 |
| 78 | Increased corneal curvature (HP:0100692) | 1.96941651 |
| 79 | Keratoconus (HP:0000563) | 1.96941651 |
| 80 | Torticollis (HP:0000473) | 1.95899195 |
| 81 | Decreased muscle mass (HP:0003199) | 1.95807390 |
| 82 | Cardiovascular calcification (HP:0011915) | 1.94853782 |
| 83 | Hyperuricemia (HP:0002149) | 1.94278311 |
| 84 | Increased purine levels (HP:0004368) | 1.94278311 |
| 85 | Abnormality of purine metabolism (HP:0004352) | 1.94080005 |
| 86 | Biconcave vertebral bodies (HP:0004586) | 1.93706996 |
| 87 | EEG with generalized epileptiform discharges (HP:0011198) | 1.90102901 |
| 88 | Aortic aneurysm (HP:0004942) | 1.90073158 |
| 89 | Vascular tortuosity (HP:0004948) | 1.87856931 |
| 90 | Drooling (HP:0002307) | 1.87118568 |
| 91 | Coronal craniosynostosis (HP:0004440) | 1.86102446 |
| 92 | Epileptiform EEG discharges (HP:0011182) | 1.85717608 |
| 93 | Hypsarrhythmia (HP:0002521) | 1.85095347 |
| 94 | Irritability (HP:0000737) | 1.85088893 |
| 95 | Short tibia (HP:0005736) | 1.84541362 |
| 96 | Poor suck (HP:0002033) | 1.83797066 |
| 97 | Long clavicles (HP:0000890) | 1.82587681 |
| 98 | Abnormality of nucleobase metabolism (HP:0010932) | 1.81789584 |
| 99 | Focal dystonia (HP:0004373) | 1.81753899 |
| 100 | Spastic diplegia (HP:0001264) | 1.81620571 |
| 101 | Chorioretinal atrophy (HP:0000533) | 1.81265751 |
| 102 | Neonatal onset (HP:0003623) | 1.80331782 |
| 103 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.79953547 |
| 104 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79324885 |
| 105 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78772563 |
| 106 | Craniofacial dystonia (HP:0012179) | 1.78749737 |
| 107 | Neurofibrillary tangles (HP:0002185) | 1.78616273 |
| 108 | Mesomelia (HP:0003027) | 1.77989423 |
| 109 | Supernumerary spleens (HP:0009799) | 1.77624514 |
| 110 | Limited hip movement (HP:0008800) | 1.77624277 |
| 111 | Malnutrition (HP:0004395) | 1.76916948 |
| 112 | Overgrowth (HP:0001548) | 1.76685168 |
| 113 | Abnormality of the labia minora (HP:0012880) | 1.76651779 |
| 114 | Athetosis (HP:0002305) | 1.76181379 |
| 115 | Fat malabsorption (HP:0002630) | 1.75972065 |
| 116 | Volvulus (HP:0002580) | 1.75502060 |
| 117 | Neonatal short-limb short stature (HP:0008921) | 1.74406169 |
| 118 | Hypoglycemic coma (HP:0001325) | 1.73744713 |
| 119 | Complement deficiency (HP:0004431) | 1.73191328 |
| 120 | Enlarged kidneys (HP:0000105) | 1.73034139 |
| 121 | Abnormality of placental membranes (HP:0011409) | 1.72534439 |
| 122 | Amniotic constriction ring (HP:0009775) | 1.72534439 |
| 123 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.72486691 |
| 124 | Spontaneous abortion (HP:0005268) | 1.72390062 |
| 125 | Metabolic acidosis (HP:0001942) | 1.71822162 |
| 126 | Gowers sign (HP:0003391) | 1.71657591 |
| 127 | Abnormality of the lower motor neuron (HP:0002366) | 1.70244974 |
| 128 | Vascular calcification (HP:0004934) | 1.70233394 |
| 129 | Cerebral inclusion bodies (HP:0100314) | 1.70210361 |
| 130 | Increased circulating renin level (HP:0000848) | 1.69860043 |
| 131 | Gaze-evoked nystagmus (HP:0000640) | 1.69446101 |
| 132 | Cerebral edema (HP:0002181) | 1.68722303 |
| 133 | Action tremor (HP:0002345) | 1.68171611 |
| 134 | Genital tract atresia (HP:0001827) | 1.68099031 |
| 135 | Spondylolisthesis (HP:0003302) | 1.68083073 |
| 136 | Alkalosis (HP:0001948) | 1.67628852 |
| 137 | Generalized tonic-clonic seizures (HP:0002069) | 1.67617818 |
| 138 | Abnormal pupillary function (HP:0007686) | 1.67426684 |
| 139 | Postaxial hand polydactyly (HP:0001162) | 1.66130217 |
| 140 | Glioma (HP:0009733) | 1.65543860 |
| 141 | Bifid tongue (HP:0010297) | 1.65529868 |
| 142 | Medial flaring of the eyebrow (HP:0010747) | 1.64761199 |
| 143 | Shallow orbits (HP:0000586) | 1.62617607 |
| 144 | Bell-shaped thorax (HP:0001591) | 1.62218389 |
| 145 | Turricephaly (HP:0000262) | 1.61926872 |
| 146 | Abnormality of macular pigmentation (HP:0008002) | 1.61811681 |
| 147 | Infantile muscular hypotonia (HP:0008947) | 1.61055803 |
| 148 | Gait imbalance (HP:0002141) | 1.61031911 |
| 149 | Renal tubular acidosis (HP:0001947) | 1.60865667 |
| 150 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.60622441 |
| 151 | Camptodactyly of toe (HP:0001836) | 1.60258386 |
| 152 | Limb dystonia (HP:0002451) | 1.60009168 |
| 153 | Conjugated hyperbilirubinemia (HP:0002908) | 1.58189253 |
| 154 | Pulmonic stenosis (HP:0001642) | 1.57274944 |
| 155 | Intestinal atresia (HP:0011100) | 1.55510859 |
| 156 | Excessive salivation (HP:0003781) | 1.54373034 |
| 157 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.53219644 |
| 158 | Vaginal atresia (HP:0000148) | 1.52410611 |
| 159 | Bowel diverticulosis (HP:0005222) | 1.51788801 |
| 160 | Follicular hyperkeratosis (HP:0007502) | 1.50432418 |
| 161 | Congenital primary aphakia (HP:0007707) | 1.50036086 |
| 162 | Ependymoma (HP:0002888) | 1.49884866 |
| 163 | Febrile seizures (HP:0002373) | 1.49861640 |
| 164 | Muscle fiber inclusion bodies (HP:0100299) | 1.49801123 |
| 165 | Pancreatic cysts (HP:0001737) | 1.49187770 |
| 166 | Pulmonary artery stenosis (HP:0004415) | 1.47038543 |
| 167 | Broad metatarsal (HP:0001783) | 1.46945824 |
| 168 | Hypothermia (HP:0002045) | 1.46352216 |
| 169 | Hypoplastic scapulae (HP:0000882) | 1.46191294 |
| 170 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.46191294 |
| 171 | Cystic hygroma (HP:0000476) | 1.45586385 |
| 172 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.45411647 |
| 173 | Optic nerve hypoplasia (HP:0000609) | 1.44810294 |
| 174 | Occipital encephalocele (HP:0002085) | 1.44557635 |
| 175 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.44045948 |
| 176 | Akinesia (HP:0002304) | 1.42742094 |
| 177 | Fetal akinesia sequence (HP:0001989) | 1.40285152 |
| 178 | Abnormality of midbrain morphology (HP:0002418) | 1.39545799 |
| 179 | Molar tooth sign on MRI (HP:0002419) | 1.39545799 |
| 180 | Palpebral edema (HP:0100540) | 1.38302558 |
| 181 | Nephrogenic diabetes insipidus (HP:0009806) | 1.38234794 |
| 182 | Clonus (HP:0002169) | 1.37478911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.51844520 |
| 2 | MINK1 | 2.77196436 |
| 3 | STK38L | 2.56075666 |
| 4 | CASK | 2.56024834 |
| 5 | MAP3K4 | 2.42506095 |
| 6 | LATS2 | 2.36958413 |
| 7 | EPHA4 | 2.28753206 |
| 8 | MAP2K7 | 2.24930020 |
| 9 | TNIK | 2.20522170 |
| 10 | NTRK2 | 2.16949110 |
| 11 | NEK1 | 2.10414849 |
| 12 | MUSK | 2.08441943 |
| 13 | PLK2 | 2.03161268 |
| 14 | PNCK | 1.98046890 |
| 15 | MAP2K4 | 1.92916693 |
| 16 | PHKG1 | 1.83580312 |
| 17 | PHKG2 | 1.83580312 |
| 18 | PRKD3 | 1.79213732 |
| 19 | LMTK2 | 1.77429621 |
| 20 | WEE1 | 1.76536856 |
| 21 | BCKDK | 1.74683415 |
| 22 | LIMK1 | 1.72556427 |
| 23 | SGK2 | 1.66103476 |
| 24 | TRIM28 | 1.64848626 |
| 25 | STK39 | 1.64629000 |
| 26 | WNK3 | 1.64208932 |
| 27 | EIF2AK3 | 1.63961434 |
| 28 | SGK223 | 1.63731153 |
| 29 | SGK494 | 1.63731153 |
| 30 | ERBB4 | 1.59802174 |
| 31 | MAP3K9 | 1.58366599 |
| 32 | PRPF4B | 1.57782058 |
| 33 | PAK6 | 1.57194838 |
| 34 | NUAK1 | 1.51556742 |
| 35 | PAK3 | 1.50734253 |
| 36 | MKNK2 | 1.48817899 |
| 37 | BRSK2 | 1.43635145 |
| 38 | NTRK3 | 1.42650891 |
| 39 | PDK3 | 1.40082018 |
| 40 | PDK4 | 1.40082018 |
| 41 | ERBB3 | 1.39086795 |
| 42 | AKT3 | 1.37692214 |
| 43 | MST4 | 1.37232026 |
| 44 | KSR1 | 1.29488663 |
| 45 | PRKCG | 1.27640746 |
| 46 | BMPR1B | 1.23987001 |
| 47 | SGK3 | 1.23600310 |
| 48 | PINK1 | 1.23503798 |
| 49 | MAP3K12 | 1.22381396 |
| 50 | SIK1 | 1.19069877 |
| 51 | TESK1 | 1.18651341 |
| 52 | MAP4K2 | 1.17669045 |
| 53 | PAK2 | 1.15795928 |
| 54 | FER | 1.15292320 |
| 55 | EPHB2 | 1.14911707 |
| 56 | CCNB1 | 1.13305993 |
| 57 | CDK14 | 1.07657049 |
| 58 | WNK4 | 1.07644996 |
| 59 | MAPK13 | 1.07055453 |
| 60 | CDK18 | 1.04710277 |
| 61 | DAPK2 | 1.04467038 |
| 62 | OXSR1 | 1.03493002 |
| 63 | TRIB3 | 1.01899573 |
| 64 | MYLK | 1.01800684 |
| 65 | CSNK1G1 | 1.01724272 |
| 66 | STK38 | 0.98760455 |
| 67 | CDK15 | 0.98218519 |
| 68 | STK3 | 0.95755151 |
| 69 | NTRK1 | 0.92667327 |
| 70 | BUB1 | 0.92267206 |
| 71 | DDR2 | 0.91163881 |
| 72 | ROCK1 | 0.90154724 |
| 73 | PTK2B | 0.88839498 |
| 74 | CDK5 | 0.87008878 |
| 75 | DYRK2 | 0.86214018 |
| 76 | CSNK1G3 | 0.86162978 |
| 77 | OBSCN | 0.82844305 |
| 78 | DMPK | 0.81686737 |
| 79 | PRKCZ | 0.81351343 |
| 80 | CSNK1A1L | 0.80333534 |
| 81 | STK24 | 0.80045731 |
| 82 | TSSK6 | 0.79846294 |
| 83 | CDK11A | 0.79757429 |
| 84 | CAMKK1 | 0.79301490 |
| 85 | GRK5 | 0.75311022 |
| 86 | CAMK2A | 0.74133333 |
| 87 | BRSK1 | 0.73318952 |
| 88 | MAP2K1 | 0.72739972 |
| 89 | PKN1 | 0.72688702 |
| 90 | EIF2AK2 | 0.70669142 |
| 91 | DYRK1A | 0.70615720 |
| 92 | LATS1 | 0.69865985 |
| 93 | SIK3 | 0.67260937 |
| 94 | BCR | 0.67136571 |
| 95 | FRK | 0.66730969 |
| 96 | PRKCE | 0.66533373 |
| 97 | PKN2 | 0.66526199 |
| 98 | ILK | 0.66135830 |
| 99 | PTK2 | 0.65627179 |
| 100 | PDK2 | 0.65234437 |
| 101 | PAK4 | 0.64920689 |
| 102 | TAOK2 | 0.63909615 |
| 103 | PIK3CA | 0.62946833 |
| 104 | PLK1 | 0.62799372 |
| 105 | FGFR1 | 0.61422810 |
| 106 | PRKCH | 0.60252659 |
| 107 | PDGFRA | 0.59894015 |
| 108 | CAMK2G | 0.58383844 |
| 109 | CSNK1G2 | 0.56453167 |
| 110 | ADRBK1 | 0.53417980 |
| 111 | PLK3 | 0.53232803 |
| 112 | EIF2AK1 | 0.51823634 |
| 113 | MKNK1 | 0.50822909 |
| 114 | ABL2 | 0.50740302 |
| 115 | ACVR1B | 0.50718787 |
| 116 | FGFR2 | 0.49703612 |
| 117 | RET | 0.49313835 |
| 118 | ROCK2 | 0.48721929 |
| 119 | GRK1 | 0.48356616 |
| 120 | ERBB2 | 0.47439697 |
| 121 | ZAK | 0.46999203 |
| 122 | BMX | 0.46044958 |
| 123 | DAPK1 | 0.44609182 |
| 124 | ARAF | 0.43506725 |
| 125 | MET | 0.42725164 |
| 126 | CDC42BPA | 0.42655109 |
| 127 | SGK1 | 0.42266111 |
| 128 | UHMK1 | 0.41711268 |
| 129 | NEK9 | 0.41647616 |
| 130 | PRKD2 | 0.41547298 |
| 131 | PRKACG | 0.39523653 |
| 132 | PRKCI | 0.39321196 |
| 133 | CAMK2D | 0.38776798 |
| 134 | CDK6 | 0.38525003 |
| 135 | CAMK2B | 0.38077341 |
| 136 | MAPK12 | 0.37729504 |
| 137 | TTK | 0.36157307 |
| 138 | CDK8 | 0.35402888 |
| 139 | TAF1 | 0.32464637 |
| 140 | GSK3A | 0.31376615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.39737380 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.90051624 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.84206038 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82204769 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.80206573 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.69554376 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64763978 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.59626659 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51481089 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.36222137 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.17819544 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14965513 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12510977 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04997528 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.00386048 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.97142300 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93713222 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88076854 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86035921 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.62239352 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61588265 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56061213 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54233898 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.49589525 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48709808 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47107615 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47012147 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46558474 |
| 29 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.40638509 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37524824 |
| 31 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28102024 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23974467 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.22555699 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15651687 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15366155 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14544439 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13613638 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12868586 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12842546 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10905200 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09588263 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09151404 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07897401 |
| 44 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.07699096 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.04014201 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.03059745 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02895864 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00732969 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00264302 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98989483 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97195684 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95172475 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95056842 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93464643 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92604417 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92008805 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91156592 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88010565 |
| 59 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.87728149 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87581083 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87138955 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86645831 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85295803 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84244088 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81552316 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.80525541 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79823465 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78462437 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78256009 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.75713562 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73834127 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72205512 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.71796579 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69194823 |
| 75 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67732010 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67533485 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66440813 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66186161 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65695465 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.62573280 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.61815224 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60462584 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.58328251 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57665523 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57012138 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.56752544 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56257682 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54007326 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51847300 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51690871 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51491842 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.51457855 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50577040 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50146909 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49208208 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49079361 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48880604 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48129220 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.47566566 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43958460 |
| 101 | Insulin secretion_Homo sapiens_hsa04911 | 0.43200609 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43171876 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40122340 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39762173 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39258918 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39157726 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.36688480 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36566801 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36456866 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35492935 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35411585 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34947852 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34699463 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34631958 |
| 115 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34219892 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.33333956 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.29285240 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27469967 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.27352049 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26886473 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.25888226 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25615985 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.24875653 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24656992 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24513048 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24404585 |
| 127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24395750 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.24020118 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23122919 |
| 130 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22772273 |
| 131 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22731194 |

